Dysregulated CD38 Expression on Peripheral Blood Immune Cell Subsets in SLE

Given its uniformly high expression on plasma cells, CD38 has been considered as a therapeutic target in patients with systemic lupus erythematosus (SLE). Herein, we investigate the distribution of CD38 expression by peripheral blood leukocyte lineages to evaluate the potential therapeutic effect of...

Descripción completa

Detalles Bibliográficos
Autores principales: Burns, Marie, Ostendorf, Lennard, Biesen, Robert, Grützkau, Andreas, Hiepe, Falk, Mei, Henrik E., Alexander, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957821/
https://www.ncbi.nlm.nih.gov/pubmed/33670902
http://dx.doi.org/10.3390/ijms22052424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957821/
https://www.ncbi.nlm.nih.gov/pubmed/33670902
http://dx.doi.org/10.3390/ijms22052424

Ejemplares similares